IL-33 levels in peripheral blood plasma and sputum of patients with bronchial asthma and their correlation with symptoms of patients, pulmonary function, and eosinophil numbers
|更新时间:2026-01-09
|
IL-33 levels in peripheral blood plasma and sputum of patients with bronchial asthma and their correlation with symptoms of patients, pulmonary function, and eosinophil numbers
Journal of Army Medical UniversityVol. 33, Issue 14, Pages: 1526-1529(2011)
Ma Xiaoyan,Luo Yaling,Lai Wenyan,Shao Jinlian,Lan Haibing,Liang Zhenyu.IL-33 levels in peripheral blood plasma and sputum of patients with bronchial asthma and their correlation with symptoms of patients, pulmonary function, and eosinophil numbers[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(14):1526-1529.
Ma Xiaoyan,Luo Yaling,Lai Wenyan,Shao Jinlian,Lan Haibing,Liang Zhenyu.IL-33 levels in peripheral blood plasma and sputum of patients with bronchial asthma and their correlation with symptoms of patients, pulmonary function, and eosinophil numbers[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(14):1526-1529.DOI:
IL-33 levels in peripheral blood plasma and sputum of patients with bronchial asthma and their correlation with symptoms of patients, pulmonary function, and eosinophil numbers
Objective To measure the IL-33 levels in the peripheral blood plasma and sputum of the patients with bronchial asthma
and to analyze their correlation with the symptoms of the patients
the pulmonary functio
n and the eosinophil numbers in the peripheral blood and sputum. Methods Eighty patients with bronchial patients and twenty normal control subjects were enrolled in the study. The IL-33 levels in the peripheral blood plasma of the patients and normal control subjects were measured by enzyme-linked immunosorbent assay (ELISA). The daytime and nighttime symptom scores of the patients were recorded
and the pulmonary function was tested. The patients were divided into a mild asthma group (FEV
1
≥80%)
a moderate asthma group (60%≤FEV
1
80%) and a severe asthma group (FEV
1
60%) according to their pulmonary function. The eosinophil numbers in the peripheral blood of the patients were recorded. Eighteen patients and eight normal control subjects were also subjected to ELISA to measure the IL-33 levels in the sputum. Their eosinophil numbers in the sputum were counted under a microscope. Results There was no significant difference of the IL-33 levels in the peripheral blood plasma between the control group and the mild asthma group (26.62±3.04 pg/ml vs 30.26±5.23 pg/ml
P0.05). The IL-33 levels in the peripheral blood plasma of the moderate and severe asthma groups were significantly higher than those in the control group (41.36±11.82 pg/ml vs 26.62±3.04 pg/ml
84.10±20.17 pg/ml vs 26.62±3.04 pg/ml
P0.05). The IL-33 levels in the peripheral blood plasma were positively correlated with the nighttime symptom scores (r=0.317
P0.05)
but not significantly correlated with the daytime symptom scores and the eosinophil numbers in the peripheral blood (r=0.173
P0.05; r=0.082
P0.05). The IL-33 levels in the peripheral blood plasma were significantly and negatively correlated with FEV
1
and expiratory peak flow (PEF) (r=-0.638
P0.05; r=-0.552
P0.05). The IL-33 levels in the sputum were positively correlated with the eosinophil numbers in sputum. Conclusion IL-33 in the peripheral blood plasma can be an indicator of the pulmonary function decline of the patients wit
h bronchial asthma
and is a promoting factor in the deterioration of asthma. The IL-33 level increase may be a cause of airway eosinophil infiltration.